David Nutt is in the news again, talking about the dangers
of alcohol (and incidentally promoting his book). He was on Radio 5
this morning, I think, but this
piece in The Guardian offers a
good summary of his current position.
I’ve
written before about the idea of single ‘harmful’ scores for individual
substances and how I find them unhelpful – not just because they’re simplistic,
but because they perpetuate a particular approach to drug regulation that I
think is naïve and therefore gets ignored.
But I just want to highlight a particularly odd position
David Nutt takes in this article. He
suggests that people should share a pint of beer, as just 5g a day is the ‘optimal’
dose. This is less than a UK ‘unit’, and
works out (apparently), as about 40ml of wine – less than a fifth of a large
glass you’d be served in a pub or a restaurant.
Even though it's been suggested focusing on this is misleading, as it's likely to have been a throwaway comment used as an illustration, the article has been endorsed by David Nutt - and more importantly it's a revealing, and inconsistent comment. But at least it’s consistently inconsistent.
As a campaigner for drug policy reform, David Nutt
acknowledges the desire to take ‘drugs’ – indeed he proposes that rather than
seeking a world in which people don’t use alcohol, we
actively create and regulate an alcohol-like intoxicant that is less harmful,
and allow people to use this.
Apart from the fact that this proposed ‘alcosynth’ relies on an assumption that we can create and adopt a genuinely new substance to take the
place of something
that has been part of society since before we were human, the rationale for
trying sounds like pragmatic harm reduction: acknowledge an impulse to get
intoxicated, and rather than ignoring it or pretending it can be legislated out
of existence, provide a safer way that it can be satisfied.
Yet suggesting an ‘optimal’ dose of 5g doesn’t do this. This is only ‘optimal’ if you don’t want to
be intoxicated. And here we get to the nub
of so much alcohol policy discussion: we
bring our own preferences and prejudices.
An ‘optimal’ dose can only be judged by the person using it, even if we
know ‘objectively’ its effects, whether in terms of intoxication or harm. I might value my long-term health less than
other people, and I might value intoxication more highly. In which case 5g isn’t so much an ‘optimal’
dose as distinctly ‘sub-optimal’.
This is a strange position for a drug reformer to take. The whole basis of David Nutt’s campaign against
the current drug laws is that they have imposed some kind of moral, philosophical
or political priority (intoxication is bad) rather than listening to ‘objective’
science. But of course there is no universal,
objective cost-benefit analysis of drugs, so the language around ‘optimal’
immediately raises the spectre of one set of personal judgements – those of ‘experts’,
speaking as an oracle* – simply replacing another.
Previously, I’ve thought of this ‘rational’ approach to drug
reform as simply naïve about not
only policymaking, but the
reality of social existence.
To summarise, the naivety about policymaking is first that telling
politicians they’re behaving irrationally isn’t a great lobbying technique, and
second imagining that ‘harm’ is the only thing drug policy could ever be about
is misguided. Not only can we not define
‘harm’ in any practical way that acts as a guide for policymakers, but there
are plenty of other (legitimate) influences on policy other than reducing ‘harm’. Balancing freedom, economy and morality is no
mean feat.
And the naivety about social existence is simply that even
if we’d like to start from some kind of ‘year zero’ in regards to drug policy, we’re
dealing with substances that have a social history. Whether we like it or not, the fact that
alcohol has been legal and available in Britain for thousands of years makes a
difference, when it’s compared with the substances that are currently illegal.
But looking at this again, I realise there’s something else
that has troubled me about this approach, at a more emotional level. I’ve been chatting about PSHE this week at
work, and a couple of us were reminiscing about how, when we were at school,
drugs education consisted of handing out booklets that contained key
information on all the major drugs – where they tended to be available, how
much they were likely to cost, what the effects were and how long these were
likely to last. Whether you ended up
taking them or not, most people looked at that booklet and did a quick
cost-benefit analysis to see which would be their preferred drug. Perhaps not the intended response, but it
illustrates a key point for drug policy: we didn’t all agree.
I think my problem, fundamentally, with the Delphi model is
that someone else has done this cost-benefit analysis for me, and I don’t
agree. (Or perhaps more accurately, they’ve
listed the costs, but not the
pleasures that might balance them.)
What I’ve previously thought is naivety about policymaking or reality
is, I think, arrogance. A belief not
that government making decisions about personal pleasures is wrong, but simply
that they’re making the wrong decisions.
Back in the first few months I was writing this blog, I said
that the
most powerful and fundamental argument the alcohol industry could make in
relation to alcohol policy would be based on liberalism, not on the
technical details of research and modelling.
I understand why it might help to undermine or muddy the waters of ‘public
health’ evidence, but that’s not really the fundamentals of this debate.
The same applies to drug policy reformers. The debate is fundamentally about freedom:
why should one person’s preferred drug (alcohol) be legal, while another’s
(cannabis, or MDMA) is illegal? Harm
helps frame this debate, but it can’t drive it.
That’s not a question of naivety or pragmatism, but ethics. Drug policy really can’t just be about
science.
*Hence the
Delphi model of research so favoured in
these approaches.